Gu Y - Search Results

1

Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer.

Zhao Z, Guo Y, Liu Y, Sun L, Chen B, Wang C, Chen T, Wang Y, Li Y, Dong Q, Ai L, Wang R, Gu Y, Li X. Zhao Z, et al. Among authors: gu y. Oncogene. 2021 Jul;40(27):4604-4614. doi: 10.1038/s41388-021-01883-6. Epub 2021 Jun 15. Oncogene. 2021. PMID: 34131286 Free PMC article.

2

A landscape of synthetic viable interactions in cancer.

Gu Y, Wang R, Han Y, Zhou W, Zhao Z, Chen T, Zhang Y, Peng F, Liang H, Qi L, Zhao W, Yang D, Guo Z. Gu Y, et al. Brief Bioinform. 2018 Jul 20;19(4):644-655. doi: 10.1093/bib/bbw142. Brief Bioinform. 2018. PMID: 28096076

3

Individualized analysis of differentially expressed miRNAs with application to the identification of miRNAs deregulated commonly in lung cancer tissues.

Yan H, Cai H, Guan Q, He J, Zhang J, Guo Y, Huang H, Li X, Li Y, Gu Y, Qi L, Guo Z. Yan H, et al. Among authors: gu y. Brief Bioinform. 2018 Sep 28;19(5):793-802. doi: 10.1093/bib/bbx015. Brief Bioinform. 2018. PMID: 28334118

4

Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.

Peng F, Wang R, Zhang Y, Zhao Z, Zhou W, Chang Z, Liang H, Zhao W, Qi L, Guo Z, Gu Y. Peng F, et al. Among authors: gu y. Mol Cancer. 2017 Jun 6;16(1):98. doi: 10.1186/s12943-017-0666-z. Mol Cancer. 2017. PMID: 28587642 Free PMC article.

5

EMT-Regulome: a database for EMT-related regulatory interactions, motifs and network.

Zhao Z, Zhou W, Han Y, Peng F, Wang R, Yu R, Wang C, Liang H, Guo Z, Gu Y. Zhao Z, et al. Among authors: gu y. Cell Death Dis. 2017 Jun 15;8(6):e2872. doi: 10.1038/cddis.2017.267. Cell Death Dis. 2017. PMID: 28617437 Free PMC article. No abstract available.

6

Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.

Zhou W, Zhao Z, Wang R, Han Y, Wang C, Yang F, Han Y, Liang H, Qi L, Wang C, Guo Z, Gu Y. Zhou W, et al. Among authors: gu y. Mol Oncol. 2017 Oct;11(10):1459-1474. doi: 10.1002/1878-0261.12112. Epub 2017 Aug 3. Mol Oncol. 2017. PMID: 28719033 Free PMC article.

7

Link synthetic lethality to drug sensitivity of cancer cells.

Wang R, Han Y, Zhao Z, Yang F, Chen T, Zhou W, Wang X, Qi L, Zhao W, Guo Z, Gu Y. Wang R, et al. Among authors: gu y. Brief Bioinform. 2019 Jul 19;20(4):1295-1307. doi: 10.1093/bib/bbx172. Brief Bioinform. 2019. PMID: 29300844

8

Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer.

Liang H, Zhao X, Wang C, Sun J, Chen Y, Wang G, Fang L, Yang R, Yu M, Gu Y, Shan H. Liang H, et al. Among authors: gu y. Mol Cancer. 2018 Jun 21;17(1):96. doi: 10.1186/s12943-018-0844-7. Mol Cancer. 2018. Retraction in: Mol Cancer. 2023 Apr 28;22(1):78. doi: 10.1186/s12943-023-01779-x PMID: 29929545 Free PMC article. Retracted.

9

LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.

Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y. Liang H, et al. Among authors: gu y. Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5. Mol Cancer. 2018. PMID: 30098599 Free PMC article.

10

Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells.

Han Y, Wang C, Dong Q, Chen T, Yang F, Liu Y, Chen B, Zhao Z, Qi L, Zhao W, Liang H, Guo Z, Gu Y. Han Y, et al. Among authors: gu y. Mol Ther Nucleic Acids. 2019 Sep 6;17:688-700. doi: 10.1016/j.omtn.2019.07.003. Epub 2019 Jul 17. Mol Ther Nucleic Acids. 2019. PMID: 31400611 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,645 results

Search Page

Filters